본문 바로가기
국가기간뉴스 통신사 연합뉴스
국가기간뉴스 통신사 연합뉴스
댓글

'수요 급증' ...화이자 백신 초저온 보관용 드라이 아이스

송고시간2020-12-03 07:11

댓글
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES
US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES

<저작권자(c) 연합뉴스, 무단 전재-재배포 금지> 2020/12/03 07:11 송고

댓글보기

오늘의 사진

전체보기
/

화보

전체보기

주제 별 포토

핫뉴스

전체보기

이 시각 주요뉴스

연합뉴스 홈

Editor's Pick

비주얼 뉴스 홈
연합뉴스 홈페이지
뉴스 검색어 입력 양식
섹션뉴스
비주얼 뉴스
테마별뉴스
뉴스+
외국어 뉴스 Other Languages
연합뉴스 팔로우
연합뉴스 페이스북 연합뉴스 트위터 연합뉴스 유튜브
연합뉴스 홈페이지 검색
뉴스 검색어 입력 양식
자동완성

    1년 365일 24시간 쉬지 않고 가동되는 실시간 뉴스를 검색해 보세요.

    본문 글자 크기 조정

    글자 크기 예시문을 확인하세요.

    연합뉴스는 국내외 뉴스를 실시간으로 전하는 대한민국 대표 뉴스 통신사입니다.

    국내 최대 규모인 590여명의 기자가 공정하고 균형 잡힌 보도를 위해 헌신합니다.

    이 뉴스 공유하기

    '수요 급증' ...화이자 백신 초저온 보관용 드라이 아이스
    /
    • US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES

      A machine makes dry ice pellets at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, November 20, 2020. - Amid a whipsaw year that saw a surge in demand for its dry ice and a shortage of the carbon dioxide needed to make it, Capitol Carbonic received a call from a prospective customer: Pfizer. The global pharmaceutical giant was on the hunt for the quarter-inch pellets Capitol Carbonic, a six-decade-old family concern, spits out of a machine resembling a giant spaghetti maker in a Baltimore warehouse -- exactly what Pfizer needs to keep its Covid-19 vaccine at just the right, very chilly, temperature. (Photo by SAUL LOEB / AFP)

      2020-12-02 11:03
    • US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES

      Dry ice pellets are seen during the manufacturing process at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, November 20, 2020. - Amid a whipsaw year that saw a surge in demand for its dry ice and a shortage of the carbon dioxide needed to make it, Capitol Carbonic received a call from a prospective customer: Pfizer. The global pharmaceutical giant was on the hunt for the quarter-inch pellets Capitol Carbonic, a six-decade-old family concern, spits out of a machine resembling a giant spaghetti maker in a Baltimore warehouse -- exactly what Pfizer needs to keep its Covid-19 vaccine at just the right, very chilly, temperature. (Photo by SAUL LOEB / AFP)

      2020-12-02 11:03
    • US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES

      An employee makes dry ice pellets at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, November 20, 2020. - Amid a whipsaw year that saw a surge in demand for its dry ice and a shortage of the carbon dioxide needed to make it, Capitol Carbonic received a call from a prospective customer: Pfizer. The global pharmaceutical giant was on the hunt for the quarter-inch pellets Capitol Carbonic, a six-decade-old family concern, spits out of a machine resembling a giant spaghetti maker in a Baltimore warehouse -- exactly what Pfizer needs to keep its Covid-19 vaccine at just the right, very chilly, temperature. (Photo by SAUL LOEB / AFP)

      2020-12-02 11:02
    • US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES

      An employee makes dry ice pellets at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, November 20, 2020. - Amid a whipsaw year that saw a surge in demand for its dry ice and a shortage of the carbon dioxide needed to make it, Capitol Carbonic received a call from a prospective customer: Pfizer. The global pharmaceutical giant was on the hunt for the quarter-inch pellets Capitol Carbonic, a six-decade-old family concern, spits out of a machine resembling a giant spaghetti maker in a Baltimore warehouse -- exactly what Pfizer needs to keep its Covid-19 vaccine at just the right, very chilly, temperature. (Photo by SAUL LOEB / AFP)

      2020-12-02 11:03
    • US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES

      Dry ice pellets are seen during the manufacturing process at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, November 20, 2020. - Amid a whipsaw year that saw a surge in demand for its dry ice and a shortage of the carbon dioxide needed to make it, Capitol Carbonic received a call from a prospective customer: Pfizer. The global pharmaceutical giant was on the hunt for the quarter-inch pellets Capitol Carbonic, a six-decade-old family concern, spits out of a machine resembling a giant spaghetti maker in a Baltimore warehouse -- exactly what Pfizer needs to keep its Covid-19 vaccine at just the right, very chilly, temperature. (Photo by SAUL LOEB / AFP)

      2020-12-02 11:02
    • US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES

      An employee holds pieces of dry ice at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, November 20, 2020. - Amid a whipsaw year that saw a surge in demand for its dry ice and a shortage of the carbon dioxide needed to make it, Capitol Carbonic received a call from a prospective customer: Pfizer. The global pharmaceutical giant was on the hunt for the quarter-inch pellets Capitol Carbonic, a six-decade-old family concern, spits out of a machine resembling a giant spaghetti maker in a Baltimore warehouse -- exactly what Pfizer needs to keep its Covid-19 vaccine at just the right, very chilly, temperature. (Photo by SAUL LOEB / AFP)

      2020-12-02 11:04
    • US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES

      An employee holds dry ice pellets at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, November 20, 2020. - Amid a whipsaw year that saw a surge in demand for its dry ice and a shortage of the carbon dioxide needed to make it, Capitol Carbonic received a call from a prospective customer: Pfizer. The global pharmaceutical giant was on the hunt for the quarter-inch pellets Capitol Carbonic, a six-decade-old family concern, spits out of a machine resembling a giant spaghetti maker in a Baltimore warehouse -- exactly what Pfizer needs to keep its Covid-19 vaccine at just the right, very chilly, temperature. (Photo by SAUL LOEB / AFP)

      2020-12-02 11:03
    • US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES

      Dry ice pellets are seen during the manufacturing process at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, November 20, 2020. - Amid a whipsaw year that saw a surge in demand for its dry ice and a shortage of the carbon dioxide needed to make it, Capitol Carbonic received a call from a prospective customer: Pfizer. The global pharmaceutical giant was on the hunt for the quarter-inch pellets Capitol Carbonic, a six-decade-old family concern, spits out of a machine resembling a giant spaghetti maker in a Baltimore warehouse -- exactly what Pfizer needs to keep its Covid-19 vaccine at just the right, very chilly, temperature. (Photo by SAUL LOEB / AFP)

      2020-12-02 11:01
    • US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES

      An employee places blocks of dry ice inside a cooler at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, November 20, 2020. - Amid a whipsaw year that saw a surge in demand for its dry ice and a shortage of the carbon dioxide needed to make it, Capitol Carbonic received a call from a prospective customer: Pfizer. The global pharmaceutical giant was on the hunt for the quarter-inch pellets Capitol Carbonic, a six-decade-old family concern, spits out of a machine resembling a giant spaghetti maker in a Baltimore warehouse -- exactly what Pfizer needs to keep its Covid-19 vaccine at just the right, very chilly, temperature. (Photo by SAUL LOEB / AFP)

      2020-12-02 11:04
    • US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES

      An employee uses a forklift to move a cooler of dry ice pellets at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, November 20, 2020. - Amid a whipsaw year that saw a surge in demand for its dry ice and a shortage of the carbon dioxide needed to make it, Capitol Carbonic received a call from a prospective customer: Pfizer. The global pharmaceutical giant was on the hunt for the quarter-inch pellets Capitol Carbonic, a six-decade-old family concern, spits out of a machine resembling a giant spaghetti maker in a Baltimore warehouse -- exactly what Pfizer needs to keep its Covid-19 vaccine at just the right, very chilly, temperature. (Photo by SAUL LOEB / AFP)

      2020-12-02 11:04
    • US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES

      An employee makes dry ice blocks at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, November 20, 2020. - Amid a whipsaw year that saw a surge in demand for its dry ice and a shortage of the carbon dioxide needed to make it, Capitol Carbonic received a call from a prospective customer: Pfizer. The global pharmaceutical giant was on the hunt for the quarter-inch pellets Capitol Carbonic, a six-decade-old family concern, spits out of a machine resembling a giant spaghetti maker in a Baltimore warehouse -- exactly what Pfizer needs to keep its Covid-19 vaccine at just the right, very chilly, temperature. (Photo by SAUL LOEB / AFP)

      2020-12-02 11:04
    • US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES

      An employee places a block of dry ice into a cooler at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, November 20, 2020. - Amid a whipsaw year that saw a surge in demand for its dry ice and a shortage of the carbon dioxide needed to make it, Capitol Carbonic received a call from a prospective customer: Pfizer. The global pharmaceutical giant was on the hunt for the quarter-inch pellets Capitol Carbonic, a six-decade-old family concern, spits out of a machine resembling a giant spaghetti maker in a Baltimore warehouse -- exactly what Pfizer needs to keep its Covid-19 vaccine at just the right, very chilly, temperature. (Photo by SAUL LOEB / AFP)

      2020-12-02 11:04
    • US-HEALTH-VIRUS-VACCINES-MANUFACTURING-ENTERPRISES

      Bags of dry ice are seen at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, November 20, 2020. - Amid a whipsaw year that saw a surge in demand for its dry ice and a shortage of the carbon dioxide needed to make it, Capitol Carbonic received a call from a prospective customer: Pfizer. The global pharmaceutical giant was on the hunt for the quarter-inch pellets Capitol Carbonic, a six-decade-old family concern, spits out of a machine resembling a giant spaghetti maker in a Baltimore warehouse -- exactly what Pfizer needs to keep its Covid-19 vaccine at just the right, very chilly, temperature. (Photo by SAUL LOEB / AFP)

      2020-12-02 11:03